Institutional investors purchased a net $725.2 thousand shares of PBYI during the quarter ended December 2012. This may signal that the smart money is gaining interest in this company as the 74.10% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 386.6 Thousand shares of Puma Biotechnology Inc
PARTNER FUND MANAGEMENT LP Bought 384.4 Thousand shares of Puma Biotechnology Inc